Showing 15 posts of 58 posts found.

Oxford University to collaborate with Oracle on COVID variant research

May 17, 2021
Sales and Marketing AI, COVID-19, Oxford, variants

In response to emerging variants of COVID-19, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS), combining …

PrecisionLife & Cyclica join forces on 30 AI drug discovery programmes

May 17, 2021
Sales and Marketing AI, drug discovery

PrecisionLife, a combinatorial analytics company, and Toronto-based drug discovery company, Cyclica, have announced a strategic partnership to co-market and offer …


Biogen to collaborate with Envisagenics on RNA splicing research

May 14, 2021
Medical Communications AI

Biogen and Envisagenics have announced a new collaboration to advance ribonucleic acid (RNA) splicing research within central nervous system (CNS) …

Exscientia launch trial of third AI-designed molecule

May 13, 2021
AI, Altzeimer's, Exscientia

Exscientia has launched Phase I trials in the US of DSP-0038 for the treatment of Alzheimer’s disease psychosis, the third …

Facio Therapies announces AI collaboration for FSHD drug design

May 11, 2021
Manufacturing and Production AI, drug discovery

Facio Therapies and Iktos have announced a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of …

Scipher Medicine to expand into autoimmune disease therapeutics

April 30, 2021
Medical Communications AI, autoimmune diseases

Scipher Medicine, a precision immunology company, announced the launch on Scipher Therapeutics on Thursday, marking the company’s shift towards the …

Exscientia enter first-ever AI cancer drug into Phase I trials

April 9, 2021
Medical Communications AI, Evotec, Exscientia, cancer treatment, oncology, pharma, pharma news

Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …

Iktos and Pfizer collaborate on AI drug design

March 2, 2021
Manufacturing and Production AI, Iktos, Pfizer

Iktos has announced that its artificial intelligence (AI) technology for de novo design will be applied to selected Pfizer small-molecule …


AstraZeneca reaches deal with RenalytixAI to develop medicine strategies for a variety of diseases

August 24, 2020
Sales and Marketing AI, chronic disease

AstraZeneca and RenalytixAI have agreed a deal to develop joint precision medicine strategies for cardiovascular, renal and metabolic diseases. The …

Yale-backed study to test efficacy of AI-selected therapy in COVID-19

July 28, 2020
Manufacturing and Production, Research and Development AI, COVID-19, clinical trial, pharma

Biopharma firm AI Therapeutics is partnering with Yale School of Medicine to launch a new clinical trial to identify the efficacy …


New research outlines guidelines for the ethical use of AI in healthcare

May 20, 2020
Research and Development AI, coronavirus

A new study published in The Lancet has called on the global health community to establish guidelines to develop and …


New antibiotic discovered by AI for the first time

February 21, 2020
Medical Communications AI, AI Clinical Trials, AI Drugs, AI antibiotics, MIT, algorithm, clinical trials

MIT researchers have identified a new antibiotic compound using a machine-learning algorithm. In the laboratory tests, the drug killed many …


FDA approves Caption Health’s AI-guided imaging system

February 10, 2020
Sales and Marketing AI, Caption Health, FDA, ultrasound, ultrasound imaging

The FDA have given marketing approval for Caption Health’s Caption Guidance and its use in cardiac ultrasound images.The technology allows …

How AI is making clinical trials more accurate and affordable

February 5, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AI Clinical Trials, Apple, Apple Watch., apple watch, clinical trials

Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …


Exscientia creates first drug using AI

January 31, 2020
Medical Communications AI, AI healthcare, ai pharma

Exscientia has created a new OCD drug using artificial intelligence to sift through potential compounds, checking them against a huge …

Latest content